Key priorities for Australian infection control: summary of findings from the launch of the Centre for Research Excellence in Reducing Healthcare Associated Infections
Katie Page A B , Nicholas Graves A , Kate Halton A , Emily J. Bailey A , Glenn R. Fulford A and Mike Whitby AA Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology, 60 Musk Avenue, Brisbane, Qld 4059, Australia.
B Corresponding author. Email: katie.page@qut.edu.au
Healthcare Infection 17(4) 133-135 https://doi.org/10.1071/HI12048
Submitted: 30 October 2012 Accepted: 2 October 2012 Published: 27 November 2012
Abstract
The launch of the Centre of Research Excellence in Reducing Healthcare Associated Infection (CRE-RHAI) took place in Sydney on Friday 12 October 2012. The mission of the CRE-RHAI is to generate new knowledge about strategies to reduce healthcare associated infections and to provide data on the cost-effectiveness of infection control programs. As well as launching the CRE-RHAI, an important part of this event was a stakeholder Consultation Workshop, which brought together several experts in the Australian infection control community. The aims of this workshop were to establish the research and clinical priorities in Australian infection control, assess the importance of various multi-resistant organisms, and to gather information about decision making in infection control. We present here a summary and discussion of the responses we received.
